Oxford BioDynamics Plc (LON:OBD – Get Free Report) shares fell 19.8% during mid-day trading on Friday . The stock traded as low as GBX 0.12 and last traded at GBX 0.14. Approximately 29,025,111 shares were traded during mid-day trading, an increase of 102% from the average session volume of 14,404,227 shares. The stock had previously closed at GBX 0.17.
Oxford BioDynamics Trading Down 19.8%
The firm has a market capitalization of £5.92 million, a price-to-earnings ratio of -0.17 and a beta of 0.42. The firm’s 50 day moving average is GBX 0.19 and its 200 day moving average is GBX 0.23. The company has a quick ratio of 2.80, a current ratio of 0.88 and a debt-to-equity ratio of 457.97.
About Oxford BioDynamics
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Featured Stories
- Five stocks we like better than Oxford BioDynamics
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
